Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group study
- 31 December 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 135-138
- https://doi.org/10.1016/0277-5379(91)90470-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trialsBritish Journal of Cancer, 1989
- Cancer Statistics, 1989CA: A Cancer Journal for Clinicians, 1989
- Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1988